Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Migraine Neurologists (US)

May 12, 2008
Sustained-release opioids
By a GLG Expert Contributor
Analysis of: New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial (www.prnewswire.com)
The availability of any existing opioid molecule as a sustained-release preparation, eg Vicodin CR, is an advance in pain management.  That being said, however, there is little evidence that the risk of abuse or addiction is less with SR opioids.  In fact, the (usually) higher doses is SR...
October 30, 2006
FDA approval for severe Alzheimer's disease
By a GLG Expert Contributor
Analysis of: Aricept (donepezil) Wins Indication for Severe Alzheimer's (www.medpagetoday.com)
It is long waited decision. I have been using donepezil for last 4 to 5 years in moderate to severe Alzheimer's disease with good results. Only, I did not have statistical data.

Page : 11 to 2 of 2

Analytics


Generated at 2009-01-07T13:00:17.563